Steve Scott
Psychiatric/Mental Health · San Antonio, TXNPI 1881283059
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.3% of the total across 236 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) at 24.3% of the total. Reporting peaked in 2024 at $3,655 and has fallen 79.0% since, to $767 in 2025. Among psychiatric/mental health clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 236 payments — averaging $32.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2K
- Johnson & Johnson$1K
- Medtronic$648
- Teva Pharmaceuticals USA, Inc.$587
- Neurocrine Biosciences, Inc.$559
- Axsome Therapeutics, Inc.$513
- plus $2K from 15 others
What the payments were for
- Travel & lodging$5327%
- Food & beverage$7,05392%
- Education$591%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 66 | $1,856 |
| Johnson & Johnson | 43 | $1,280 |
| Medtronic | 8 | $648 |
| Teva Pharmaceuticals USA, Inc. | 19 | $587 |
| Neurocrine Biosciences, Inc. | 14 | $559 |
| Axsome Therapeutics, Inc. | 10 | $513 |
| Bard Peripheral Vascular, Inc. | 4 | $452 |
| AbbVie | 16 | $354 |
| Vanda Pharmaceuticals Inc. | 4 | $279 |
| Alkermes, Inc. | 13 | $257 |
| Otsuka America Pharmaceutical, Inc. | 22 | $238 |
| AstraZeneca | 2 | $226 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $125 |
| Lundbeck LLC | 3 | $67 |
| Almatica Pharma LLC | 3 | $65 |
| Bausch Health US, LLC | 2 | $38 |
| Althera Pharmaceuticals LLC | 2 | $29 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $27 |
| Biogen | 1 | $17 |
| Merck | 1 | $13 |
| Novo Nordisk | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CAPLYTA$747
- VenaSeal$481
- SPRAVATO$382
- Auvelity$375
- Fanapt$243
- Austedo XR$242
- INGREZZA$235
- INVEGA SUSTENNA$233
- BREZTRI$125
- INVEGA TRINZA$125
- VRAYLAR$125
- UZEDY$125
- NURTEC ODT$125
- FARXIGA$101
How this compares
$7,644 in reported general payments places this provider in the 90th percentile of 2,724 psychiatric/mental health providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Quetiapine Fumarate ErQuetiapine Fumarate | 12 | $1,901 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in San Antonio
- Monique GonzalezSan Antonio$126K
- Geoffrey GonzalesSan Antonio$57K
- Sara Koenig LangstonSan Antonio$27K
- Peter TorciviaSan Antonio$13K
- Tracy HicksLongview$684K
- Natalie TellezHouston$602K
- Karah BrashierRichardson$567K
- Grant DavisRichardson$360K
- Victor IlogEl Paso$167K
- Lisa ShamblinGrapevine$163K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.